Curetis Provides Business Update for the First Nine Months of 2019
(WorldNews Belgium)

Curetis Provides Business Update for the First Nine Months of 2019 14 Nov 2019 08:00 CET Company Name - ISN Market Symbol - Curetis Provides Business Update for the First Nine Months of 2019 - Signed IVD partnership for Ares Genetics - Progressed implementation of the Curetis - OpGen business combination with S4 filing - More than tripled total contract order volume received year-over-year to EUR 3.4 million in 9M-2019 - Revenue growth of approximately 16% - Near-term FDA decision on clearance of Unyvero LRT for BAL specimen expected Amsterdam, the Netherlands, Holzgerlingen, Germany, and San Diego, CA, USA, November 14, 2019, 07:00 am CET -- Curetis N.V. (the `Company` and, together with...